Filana Therapeutics, Inc. (FLNA)
1.955
-0.04
(-1.76%)
USD |
NASDAQ |
Mar 16, 16:00
1.97
+0.02
(+0.77%)
After-Hours: 20:00
Filana Therapeutics Shareholders Equity (Quarterly) : 74.40M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| cbdMD, Inc. | 9.008M |
| BioMarin Pharmaceutical, Inc. | 6.087B |
| Amicus Therapeutics, Inc. | 274.24M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Spero Therapeutics, Inc. | 26.49M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 118.36M |
| Total Liabilities (Quarterly) | 43.95M |
| Current Ratio | 2.229 |